Integrating "Physical Intelligence" to Accelerate Next-Gen Drug Validation and Bio-AX Revolution SANTA CLARA, CA, ...
AI could review data sets to assist clinical scientists ...
Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...
A new review titled Artificial Intelligence and the Discovery of Antibiotics: Reinventing with Opportunities, Challenges, and ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the AI stocks that will go to the moon. On February 18, Recursion ...
MindRank, a clinical-stage artificial intelligence (AI)-empowered drug discovery company, today announced that the first ...
Amazon S3 on MSN
How generative AI is accelerating drug discovery
Generative AI is transforming the biotechnology world at record speed. From designing drug compounds in silico to advancing precision medicine through deep genomic and clinical analysis, AI is ...
Apheris's ADMET Network will combine proprietary datasets in a privacy-preserving environment to accelerate AI drug discovery models.
CLEVELAND, OHIO, OH, UNITED STATES, February 24, 2026 /EINPresswire.com/ -- The Bommer Group, a life sciences-focused ...
Integrating AI with advanced robotics to create self-driving labs (SDL) is a promising approach to tackling molecular discovery. A new SDL system, called LUMI-lab, combines large-scale molecular ...
Cosmos Health Inc. ('Cosmos Health' or the 'Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its ...
Physical AI firm Medra leased an entire building in SoMa, months after announcing plans to build one of the country's largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results